Acclarent

Acclarent, Inc. is a medical device company focused on minimally invasive technologies for Ear, Nose, and Throat (ENT) surgical procedures. Founded in 2004 and headquartered in Irvine, California, Acclarent operates in over 45 countries and employs around 300 people. The company was acquired by Johnson & Johnson's Ethicon Inc. in 2010 and is set to be acquired by Integra LifeSciences in April 2024. Acclarent offers more than 40 FDA-approved devices aimed at treating sinus and eustachian tube conditions. Notable products include the Relieva Balloon Sinuplasty, which allows for sinus treatment without traditional surgery, and the Aera balloon, designed for chronic eustachian tube dysfunction. Their products are primarily used by ENT surgeons in outpatient and office-based settings. With over 500 patents filed, Acclarent demonstrates a strong commitment to innovation in surgical instruments and medical equipment, enhancing procedural success for physicians across various experience levels.